Shandong Teamgene Technology Co. Ltd. A Capital Reinvestment Ratio

Latest as of December 2022: 2.92x

Shandong Teamgene Technology Co. Ltd. A capital reinvestment ratio. Shandong Teamgene Technology Co. Ltd. A (603151) has a Capital Reinvestment Ratio of 2.92x as of December 2022, meaning it reinvests 3% of its operating cash flow (CN¥59.07 Million) in capital expenditures (CN¥172.41 Million). See Shandong Teamgene Technology Co. Ltd. A (603151) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.92x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥59.07 Million
CNY

Capital Expenditures

CN¥172.41 Million
CNY

Data as of

Dec 2022
Most recent filing

Capital Reinvestment Ratio of Shandong Teamgene Technology Co. Ltd. A (2020–2022)

Capital reinvestment ratio of Shandong Teamgene Technology Co. Ltd. A from 2020 to 2022. This chart tracks Shandong Teamgene Technology Co. Ltd. A's Capital Reinvestment Ratio across 3 annual periods. See Shandong Teamgene Technology Co. Ltd. A financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Shandong Teamgene Technology Co. Ltd. A Capital Reinvestment Ratio by Year (2020–2022)

Shandong Teamgene Technology Co. Ltd. A capital reinvestment ratio by year from 2020 to 2022. For the full cash flow conversion analysis, see 603151 cash generation efficiency.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2022 2.92x CN¥59.07 Million CN¥172.41 Million ▲ +294.4%
2021 0.74x CN¥131.51 Million CN¥97.31 Million ▲ +443.7%
2020 0.14x CN¥169.11 Million CN¥23.02 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow